Skip to main content
Clinical Trials/EUCTR2006-005391-40-IT
EUCTR2006-005391-40-IT
Active, not recruiting
Not Applicable

Study on the effect of intra-articular infiltrations of aulogous platelet gel as inhibitor of erosion in rheumatoid arthritis patients - ND

AZIENDA OSPEDALIERA SENESE0 sitesJune 5, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Patients with Rheumatoid Arthritis
Sponsor
AZIENDA OSPEDALIERA SENESE
Status
Active, not recruiting
Last Updated
12 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 5, 2007
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA SENESE

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with RA for longer than 6 months and less than 2 years.
  • 2\. Disease in active phase (DAS 28 \>5\.1, SDAI \>24\.5\)
  • 3\. Signs of erosions in at least 1 articular site
  • 4\. Positive reactions for anti\-CCP's antibodies.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\. Systemic infections 3 motnhs prior enrollment.
  • 2\. HCV and HBV infections.
  • 3\. pregnancy.
  • 4\.dermtatitis or infections present in studied sites.
  • 5\. Neoplasiae.
  • 6\. any tipe of infiltration present in studied sites during the last 3 months prior enrollment
  • 7\.Bisphosphonate i.v. use or teriparatide.
  • 8\. corticosteroid use at doses higher than 7,5 mg Prednisone equivalent.

Outcomes

Primary Outcomes

Not specified

Similar Trials